Naturex's (Avignon, France) nine-month consolidated revenue rose 16.7%, reflecting solid markets in developed countries as well as growing contributions from emerging markets.
For the period from Jan. through Sept. 2012, the company said consolidated revenue was €223.1 million, up 16.7% from last year's same period. At constant exchange rates, revenue grew 11.9%, bolstered by strong gains of selected currencies in the period and notably the US dollar.
Emerging markets in Eastern Europe, Asia, Latin America, Africa and the Middle East accounted for 16.9% share of total group revenue during the period, up from 14.1% one year earlier, with 40.5% year-on-year growth for the first nine months of 2012. The Europe and Africa region had revenue growth of 8.1%, the Americas revenue grew 30.9% and Asia-Pacific grew 12.3% (up 6.7%, 21.4% and 5.7%, respectively at constant exchange rates).
"These performances for the first nine months of 2012 confirm the relevance of Naturex's positioning both in mature markets marked by more selective growth trends and the faster-growing emerging countries," said Thierry Lambert, Naturex's Chairman and CEO.
Naturex’s food and beverage division had nine-month revenue of €142.8 million, up 11.9% (8.4% at constant exchange rates), with accelerating sales in the US and emerging countries that offset weaker consumer spending in Europe and the slowdown for the distribution of ingredients of its Australian subsidiary.
By segment, nutrition and health marked further gains, mainly in the US market, with revenue of €66.5 million, up 26.1%. Personal care had revenue of €3.6 million, witrh strong growth from custom-designed extracts for cosmetics applications. Miscellaneous and toll extraction had revenue of €10.2 million, up 17.1%.
